Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03704350 · ClinicalTrials.gov registry record · NA

Influence of Obesity on Endogenous Oxalate Synthesis

A NA study of Kidney Stone, sponsored by University of Alabama at Birmingham.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT03704350 is a NA study of Kidney Stone that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 40 participants, below the 191-participant average among 28 other Kidney Stone trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03704350, a NA study of Kidney Stone, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

There is increasing evidence that obesity is associated with increased urinary oxalate excretion, an important risk factor for calcium oxalate stone formation. By the administration of a controlled low oxalate diet the investigators will estimate endogenous oxalate synthesis in both non-obese and obese non-kidney-stone forming adults. This study seeks to thusly increase the understanding of the relationships between obesity and endogenous oxalate synthesis to serve as a platform to develop novel therapies for stone prevention.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT controlled diet

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2019-05-24
Est. Completion 2026-12-01
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT03704350

The ClinicalTrials.gov registry entry for NCT03704350 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 191-participant average among 28 other Kidney Stone trials with a reported enrollment target (79% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Kidney Stone appearing as the primary indexed condition, and to 1 intervention - of which controlled diet is the first listed.

NCT03704350 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT03704350 about?

NCT03704350 is a clinical study titled "Influence of Obesity on Endogenous Oxalate Synthesis". There is increasing evidence that obesity is associated with increased urinary oxalate excretion, an important risk factor for calcium oxalate stone formation. By the administration of a controlled low oxalate diet the investigators will estimate endogenous oxalate synthesis in both non-obese and ob...

What is the current status of trial NCT03704350?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2019-05-24. Estimated completion is 2026-12-01.

What conditions does trial NCT03704350 study?

This clinical trial studies the following conditions: Kidney Stone.

What interventions are being tested in trial NCT03704350?

The interventions under investigation include: controlled diet (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03704350?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03704350 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Kidney Stone

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.